PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Prime Medicine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.83+0.36 (+10.37%)
Close on Oct 19, 2026
- Market cap
- $678.77M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Prime Medicine's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 6, 2026 | Jul 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 23, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2026 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2025 | Sep 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2025 | Jul 15, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Aug 1, 2025 | Jul 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 16, 2025 | May 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 22, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2025 | Mar 18, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 28, 2025 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 24, 2024 | Oct 24, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 28, 2024 | Sep 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 12, 2024 | SEC EDGAR |
| Current report | 8-K | May 17, 2024 | May 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 10, 2024 | SEC EDGAR |
| Current report | 8-K | May 10, 2024 | May 10, 2024 | SEC EDGAR |